Ass. Prof. Michal Vrablík, MD, PhD (CZ)

FRIDAY, 5th June

Time Lecture Speaker
08:45 Opening Ceremony  
  CVD prevention: what has been achieved and what lies ahead  
09:00 Epidemiology & mortality of cardiovascular disease in European region Martin Bobak (UK)
09:30 Pharmacoeconomic insight into CVD mortality decline Jana Skoupa (CZ)
10:00 How can we impact on CVD mortality? 20 years of following the trends Renata Cifkova (CZ)
10:30 Break  
  Residual cardiovascular risk: different viewpoints- one goal  
11:00 What is residual CVD risk and is it important? Michal Vrablik (CZ)
11:30 Markers of residual CVD risk and its assessment Wolfgang Koenig (DE)
12:00 Can we reduce residual CVD risk associated with hypertension? Charalambos Vlachopoulos (GR)
12:30 Interactive session – where theory meets practice  
13:00 Lunch  
14:00 Lowering of residual CVD risk through lipid lowering: what are the options? Nina Gotcheva (BG)
14:30 Novel therapies of dyslipidemia – will we eliminate residual CVD risk? Richard Ceska (CZ)
15:00 Break  
15:15 Management of residual CVD risk in T2DM Zeljko Reiner (HR)
15:45 Lowering CVD risk in type two diabetes John Betteridge (UK)
16:15 Interactive session – where theory meets practice  

SATURDAY, 6th June

Time Lecture Speaker
  Special questions in CVD prevention  
09:00 CVD risk assessment and intervention in the elderly: is it ever too late? Rafael Bitzur (IL)
09:30 Treatment of patients with low HDL: today and in the future Maciej Banach (PL)
10:00 How to use antiplatelet therapy in different clinical settings? Petr Polasek (CA)
10:30 Interactive session – where theory meets practice  
11:00 Break  
11:30 Resistant hypertension: from diagnosis to management Karlis Trusinskis (LV)
12:00 Novel aspects of combination therapy of hypertension Konstantinos Tsioufis (GR)
12:30 Closing remarks  


Live Online Broadcasting

Watch live online according to the conference programme on 5th and 6th June 2015


Athens, June 5-6, 2015

4th CME CVS 2014

Summary, lectures, archive

Live Broadcasting